The primary objective of the study is the evaluation of efficacy of a mouthwash cointaining Chlorexidine (CHX) 0.09% + HA + Citrox (test group) on the quality of wound healing and the presence plaque formation and gingival inflammation in the post-surgical phase. Futhermore stains, discolorations and adverse effects will be eventually recorded. Control group will be represented by the use of a CHX 0.12% mouthwash.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
32
The patient will use the assigned mouthwash starting 24 hours after the surgical procedures and continuing twice a day for 14 days.
The patient will use the assigned mouthwash starting 24 hours after the surgical procedures and continuing twice a day for 14 days.
Sapienza University of Rome
Rome, Rome, Italy
Oedema
Presence of absence will be recorded (1 or 0).
Time frame: 1, 3, 7 an 14 days
Early Healing Score
The score comprises three parameters (Clinical signs of re-epithelialization, hemostasis and inflammation) and ranges from 0 (worst healing) to 10 (best healing)
Time frame: 24 hours post surgery, 3, 7 and 45 days post surgery
Plaque Index modified by Turesky
Time frame: 1,3,7 and 14 days post surgery
Gingival Index modified by Trombelli
Time frame: 1,3,7 and 14 days post surgery
Lobene Index modified
Presence of stains or discolorations of teeth and mucosae
Time frame: 1,3,7 and 14 days post surgery
Adverse effects
Disgeusia, mouth ulcers
Time frame: 1,3,7 and 14 days post surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.